Richard T Kenney's Net Worth
-$12.8 Thousand
Who is Richard T Kenney?
Richard T Kenney does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., and Sonnet BioTherapeutics Holdings, Inc..
SEC CIK
Richard T Kenney's CIK is 0001606653
Past Insider Trading and Trends
2021 was Richard T Kenney's most active year for acquiring shares with 3 total transactions. Richard T Kenney's most active month to acquire stocks was the month of December. 2023 was Richard T Kenney's most active year for disposing of shares, totalling 1 transactions. Richard T Kenney's most active month to dispose stocks was the month of December. 2021 saw Richard T Kenney paying a total of $38,600.00 for 50,000 shares, this is the most they've acquired in one year. In 2023 Richard T Kenney cashed out on 14,627 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNE DESIGN CORP. No price found
Chief Medical OfficerRichard T Kenney owns 7,522 units of Common Stock. From 2014 to 2016 Richard T Kenney acquired a total of 7,000 shares in IMMUNE DESIGN CORP..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,341.00% | 7K |
—
|
—
| 7.52K |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sonnet BioTherapeutics Holdings, Inc. (SONN) Snapshot price: $1.4199
Chief Medical OfficerRichard T Kenney owns 18,198 units of Common Stock which is worth $25,839.34. From 2021 to 2023 Richard T Kenney acquired a total of 79,254 shares in Sonnet BioTherapeutics Holdings, Inc. at a cost of $38,600.00, Richard also disposed a total of 14,627 shares of Sonnet BioTherapeutics Holdings, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 18.2K |
Jan 7
| |||
Form 4
| +29.25% | 14.63K |
—
|
—
| 64.63K |
Dec 14
| |||
Form 4
| +42.86% | 15K |
$1.54 | $23,100.00 | 50K |
Jun 9
| |||
Form 4
| +40.00% | 10K |
$1.55 | $15,500.00 | 35K |
May 19
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||